These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10789964)

  • 1. The difficult choice of chemotherapy in patients with unresectable non-small-cell lung cancer.
    Tamburini M; Buccheri G; Brunelli C; Ferrigno D
    Support Care Cancer; 2000 May; 8(3):223-8. PubMed ID: 10789964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews.
    Silvestri G; Pritchard R; Welch HG
    BMJ; 1998 Sep; 317(7161):771-5. PubMed ID: 9740561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
    Pacchiana MV; Capelletto E; Carnio S; Gridelli C; Rossi A; Galetta D; Montagna ES; Bordi P; Ceribelli A; Cortinovis D; Scotti V; Martelli O; Valmadre G; Del Conte A; Miccianza A; Morena R; Rosetti F; Di Maio M; Ostacoli L; Novello S
    Clin Lung Cancer; 2017 Jul; 18(4):381-387. PubMed ID: 27965013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients preferences in chemotherapy for advanced non-small-cell lung cancer.
    Hirose T; Horichi N; Ohmori T; Kusumoto S; Sugiyama T; Shirai T; Ozawa T; Ohnishi T; Adachi M
    Intern Med; 2005 Feb; 44(2):107-13. PubMed ID: 15750269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians.
    Gironés R; Torregrosa D; Gómez-Codina J; Maestu I; Tenias JM; Rosell R
    Clin Transl Oncol; 2012 Mar; 14(3):183-9. PubMed ID: 22374421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non-small cell lung cancer and their family caregivers.
    Yanwei L; Minghui F; Manman Q; Zhuchun Y; Dongying L; Zhanyu P
    Curr Probl Cancer; 2018; 42(3):358-366. PubMed ID: 29731164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
    Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
    Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy.
    Jiang SL; Liu HJ; Liu ZC; Liu N; Liu R; Kang YR; Ji JG; Zhang C; Hua BJ; Kang SJ
    Chin J Integr Med; 2017 May; 23(5):331-337. PubMed ID: 26142337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' preferred and perceived roles in making decisions about adjuvant chemotherapy for non-small-cell lung cancer.
    Moth E; McLachlan SA; Veillard AS; Muljadi N; Hudson M; Stockler MR; Blinman P
    Lung Cancer; 2016 May; 95():8-14. PubMed ID: 27040845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life Achieved by Carboplatin Plus Etoposide as Third-Line Chemotherapy Compared with Best Supportive Care in Non-Small Cell Lung Cancer Stage IIIB/IV.
    Maneechawakajorn J; Hathaisanguan S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S175-81. PubMed ID: 27266233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics.
    Trippoli S; Vaiani M; Lucioni C; Messori A
    Pharmacoeconomics; 2001; 19(8):855-63. PubMed ID: 11596837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support.
    Brundage MD; Feldman-Stewart D; Cosby R; Gregg R; Dixon P; Youssef Y; Mackillop WJ
    Patient Educ Couns; 2001 Nov; 45(2):149-57. PubMed ID: 11687329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in and Determinants of Quality of Life in Patients With Advanced Non-Small-Cell Lung Cancer Undergoing Initial Chemotherapy.
    Dai YL; Yang CT; Chen KH; Tang ST
    J Nurs Res; 2017 Jun; 25(3):203-215. PubMed ID: 28481816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Dancey J; Shepherd FA; Gralla RJ; Kim YS
    Lung Cancer; 2004 Feb; 43(2):183-94. PubMed ID: 14739039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of life of non-small cell lung cancer patients treated with chemotherapy.
    Karczmarek-Borowska B; Pelc M; Rabiej E; Grądalska-Lampart M
    Pneumonol Alergol Pol; 2014; 82(4):349-57. PubMed ID: 24964238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy.
    Pujol JL; Roch B; Roth C; Mérel JP
    PLoS One; 2018; 13(5):e0197605. PubMed ID: 29799879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.